John Varkarakis
Athens, ESYE31, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Association of patients' sex with treatment outcomes after intravesical bacillus Calmette-Guérin immunotherapy for T1G3/HG bladder cancer.
Journal: World journal of urology
Published: November 14, 2020
Risk factors for residual disease at re-TUR in a large cohort of T1G3 patients.
Journal: Actas urologicas espanolas
Published: June 30, 2020
Irreversible Electroporation for the Ablation of Prostate Cancer.
Journal: Current urology reports
Published: September 04, 2019
Predictors of oncological outcomes in T1G3 patients treated with BCG who undergo radical cystectomy.
Predictors of oncological outcomes in T1G3 patients treated with BCG who undergo radical cystectomy.
Journal: World journal of urology
Published: March 01, 2018
Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought.
Journal: World journal of urology
Published: February 20, 2018
Serum testosterone as a biomarker for second prostatic biopsy in men with negative first biopsy for prostatic cancer and PSA>4ng/mL, or with PIN biopsy result.
Journal: International braz j urol : official journal of the Brazilian Society of Urology
Published: March 16, 2015
Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Guérin: results of a retrospective multicenter study of 2451 patients.
Journal: European urology
Published: March 03, 2014
Minimally invasive approach in the management of upper- urinary-tract tumours.
Journal: Scandinavian journal of urology and nephrology
Published: November 11, 2011
Showing 1-9 of 9
Last Updated: 09/26/2026